Alerts and recalls

Get emails for this topic

Guidance and regulation

• National Institute for Health and Clinical Excellence (NICE) guidelines on dental recall
  • Guidance
  • 24 March 2011
  • Department of Health and Social Care

See more guidance and regulation in this topic

News and communications

• Class 4 Medicines Defect Information: Dawa Limited, Paracetamol 500mg, 1000mg Film-Coated Tablets, EL (24)A/21
  • 10 June 2024
  • Medicines and Healthcare products Regulatory Agency
  • Medical safety alert
• Field Safety Notices: 27 to 31 May 2024
  • 7 June 2024
  • Medicines and Healthcare products Regulatory Agency
  • Medical safety alert
• Class 2 Medicines Recall: Desitin Pharma UK Ltd, Lamotrigine Desitin 10mg/ml Oral Suspension, EL(24)A/20
  • 6 June 2024
  • Medicines and Healthcare products Regulatory Agency
  • Medical safety alert
• Class 3 Medicines Recall: Neuraxpharm UK Ltd, Atomoxetine 10mg, 18mg, 25mg, 40mg Capsules, EL(24)A/19
  • 5 June 2024
  • Medicines and Healthcare products Regulatory Agency
  • Medical safety alert
• Class 4 Medicines Defect Information: Manx Healthcare Ltd., Betamethasone Valerate 0.1% Ointment, EL(24)A/18
  • 3 June 2024
  • Medicines and Healthcare products Regulatory Agency
  • Medical safety alert

See more news and communications in this topic

Research and statistics

• Public Assessment Report of the reclassification of Buscopan IBS Relief, Hyoscine Butylbromide 10mg tablets
  • 11 February 2022
  • Medicines and Healthcare products Regulatory Agency
  • Research
• Report of the Commission on Human Medicine’s Expert Working Group on benefit-risk and risk minimisation measures of the yellow fever vaccine
  • 21 November 2019
  • Commission on Human Medicines
  • Independent report

See more research and statistics in this topic

Organisations

• Medicines & Healthcare products Regulatory Agency
• Department of Health & Social Care
• Commission on Human Medicines